Clinical Trial Update: Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase 1/2 clinical trial of an anti-GPC3 CAR-T cell therapy for GPC3-positive advanced hepatocellular carcinoma, sponsored by Xi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Anti-GPC3 CAR T (CAR T-cell therapy targeting Glypican-3 (GPC3))

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN